Stock Scorecard



Stock Summary for Collegium Pharmaceutical Inc (COLL) - $27.33 as of 12/8/2023 8:46:13 PM EST

Total Score

9 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for COLL

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for COLL

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for COLL

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for COLL

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for COLL

Collegium Pharmaceutical ( NASDAQ:COLL ) Stock Rating Lowered by StockNews.com 12/7/2023 7:50:00 AM
Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent 11/27/2023 1:00:00 PM
Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent - Collegium Pharmaceutical ( NASDAQ:COLL ) 11/27/2023 1:00:00 PM
Collegium Pharmaceutical ( NASDAQ:COLL ) Stock Rating Upgraded by StockNews.com 11/16/2023 7:22:00 AM
Catalyst Pharmaceutical ( CPRX ) Reports Next Week: Wall Street Expects Earnings Growth 11/1/2023 2:01:00 PM
Collegium Pharmaceutical ( COLL ) Reports Next Week: Wall Street Expects Earnings Growth 10/31/2023 2:01:00 PM
Exscientia PLC Sponsored ADR ( EXAI ) Stock Jumps 13.5%: Will It Continue to Soar? 10/12/2023 7:47:00 AM
OGN: 3 Pharma Stocks Ready to Shine This Week 10/10/2023 1:59:00 PM
Zevra Therapeutics Appoints Neil F. McFarlane as President, Chief Executive Officer and Director 10/10/2023 11:30:00 AM
Zevra Therapeutics Appoints Neil F. McFarlane as President, Chief Executive Officer and Director - Zevra Therapeutics ( NASDAQ:ZVRA ) 10/10/2023 11:30:00 AM

Financial Details for COLL

Company Overview

Ticker COLL
Company Name Collegium Pharmaceutical Inc
Country USA
Description Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2023
Next Earnings Date 2/21/2024

Stock Price History

Last Day Price 27.33
Last Day Price Updated 12/8/2023 8:46:13 PM EST
Last Day Volume 0
Average Daily Volume N/A
52-Week High 30.22
52-Week Low 20.83
Last Price to 52 Week Low 31.20 %

Valuation Measures

Trailing PE 113.88
Industry PE 57.56
Sector PE 62.37
5-Year Average PE 29.50
Free Cash Flow Ratio 2.54
Industry Free Cash Flow Ratio 10.37
Sector Free Cash Flow Ratio 31.15
Current Ratio Most Recent Quarter 1.16
Total Cash Per Share 10.75
Book Value Per Share Most Recent Quarter 5.41
Price to Book Ratio 4.98
Industry Price to Book Ratio 4.33
Sector Price to Book Ratio 19.59
Price to Sales Ratio Twelve Trailing Months 1.63
Industry Price to Sales Ratio Twelve Trailing Months 10.29
Sector Price to Sales Ratio Twelve Trailing Months 5.61

Share Statistics

Total Shares Outstanding 32,610,900
Market Capitalization 891,255,897
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Dividend King? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00 %
5-Year Dividend Payments Count 0
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 5,198.00 %
Annual Earnings Growth -134.96 %
Reported EPS 12 Trailing Months 0.24
Reported EPS Past Year 0.36
Reported EPS Prior Year 0.56
Net Income Twelve Trailing Months 9,016,000
Net Income Past Year -25,002,000
Net Income Prior Year 71,517,000
Quarterly Revenue Growth YOY 7.60 %
5-Year Revenue Growth -7.22 %

Balance Sheet

Total Cash Most Recent Quarter 350,598,000
Total Cash Past Year 173,688,000
Total Cash Prior Year 186,426,000
Net Cash Position Most Recent Quarter -360,444,000
Net Cash Position Past Year -527,263,000
Long Term Debt Past Year 700,951,000
Long Term Debt Prior Year 249,985,000
Total Debt Most Recent Quarter 711,042,000
Equity to Debt Ratio Past Year 0.22
Equity to Debt Ratio Most Recent Quarter 0.20
Total Stockholder Equity Past Year 194,842,000
Total Stockholder Equity Prior Year 202,928,000
Total Stockholder Equity Most Recent Quarter 178,873,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.81
MACD Signal 0.80
20-Day Bollinger Lower Band 20.49
20-Day Bollinger Middle Band 23.56
20-Day Bollinger Upper Band 26.63
Beta 0.93
RSI 68.77
50-Day SMA 23.96
200-Day SMA 20.89

System

Modified 12/10/2023 10:22:12 AM EST